ruben99a7
Posts: 4
New Member
Send a PM
Give a Hug
|
U.S. regulators approved the first generic rival to Johnson & Johnson's Duragesic pain relief skin patch. Mylan Laboratories Inc. will produce several different strengths of the patch, known generically as the fentanyl transdermal system, and launch the product immediately. Johnson & Johnson's annual sales of the patch total about $1.63 billion. Mylan, the biggest U.S. maker of generic drugs, had hoped to launch its copycat version last year, but the FDA granted J&J an additional six months of market exclusivity in return for testing the drug's safety and effectiveness in children. Has anyone had experience using this? |
The topic has been locked.
|
